Sotera Health (SHC) Stock Forecast & Price Target

SHC$16.61+0.31 +1.90%
Medical - Diagnostics & ResearchGrowth StockHigh Quality
Compare
Market cap$4.74BEnterprise value$7.09BRevenue (TTM)$1.22BMarket position—

Score

62
Neutral
Value
51
Quality
66
Growth
68

Sotera Health Company price target

SHC
Low$19.00
Average$21.33
High$25.00
Upside vs current price+28.4%

The average target of $21.33 is +28.4% versus the current SHC price of $16.61.

Sotera Health Company analyst ratings

RatingAnalysts
Strong buy3
Buy5
Hold2
Sell0
Strong sell1
ConsensusBuy

11 analysts cover SHC.

Sotera Health Company EPS and revenue estimates

SHC shows the next fiscal years with at least three analysts: 2026 EPS $0.98, 2027 EPS $1.07. A thinner year is left off this table.

Fiscal yearEPS estimateRevenue estimate
2026$0.98$1.25B
2027$1.07$1.32B

Is Sotera Health Company a buy or sell?

Of the 11 analysts covering Sotera Health Company, 8 rate it a buy (3 strong buy and 5 buy), 2 rate it a hold, and 1 rates it a sell (0 sell and 1 strong sell).

The SHC consensus label is Buy, beside 8 buy-side ratings and 1 sell-side ratings.

The average target of $21.33 implies +28.4% versus the current price of $16.61.

Those 11 ratings on SHC are a headcount, and the label on file is Buy.

Reading the Sotera Health Company forecast

The SHC target band runs from $19.00 to $25.00. The average inside that band is $21.33.

Set next to the $16.61 SHC quote, that average is +28.4%.

Ratings on the Sotera Health Company cluster: 8 of 11 analysts are on the buy side, 2 are at hold, and 1 is on the sell side, and the published consensus is Buy.

Recent SHC revisions are two-sided: 0 upgrades and 1 downgrades.

The SHC EPS path from 2026 ($0.98) to 2027 ($1.07) is rising.

Only 11 analysts cover SHC, so the average rests on a short list.

Sotera Health Company forecast questions

What is the SHC price target?

The published range for SHC is $19.00 to $25.00, with an average of $21.33. That average is +28.4% versus the current price of $16.61.

Is Sotera Health Company a buy or sell?

Of the 11 analysts covering Sotera Health Company, 8 rate it a buy, 2 rate it a hold, and 1 rates it a sell. The consensus is Buy, and the SHC headcount is 8 buy, 2 hold, and 1 sell.

What is the EPS estimate for Sotera Health Company?

Analyst EPS estimates for Sotera Health Company: 2026 $0.98, 2027 $1.07.

What is the revenue estimate for Sotera Health Company?

Analyst revenue estimates for Sotera Health Company: 2026 $1.25B, 2027 $1.32B.

How many analysts cover SHC?

11 analysts cover SHC. Their consensus on SHC is Buy, across those 11.

SHC price $16.61 +0.31 +1.90%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener